PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $854,965 | -21.1% | 102,391 | +25.7% | 0.00% | – |
Q2 2023 | $1,083,197 | -93.7% | 81,443 | -94.5% | 0.00% | -100.0% |
Q1 2023 | $17,059,563 | +29.1% | 1,473,192 | -8.8% | 0.01% | +20.0% |
Q4 2022 | $13,216,000 | +6253.8% | 1,615,627 | +4415.1% | 0.01% | – |
Q3 2022 | $208,000 | -20.0% | 35,783 | +24.9% | 0.00% | – |
Q1 2022 | $260,000 | -99.5% | 28,649 | -98.9% | 0.00% | -100.0% |
Q4 2021 | $51,204,000 | -9.8% | 2,502,687 | +12.6% | 0.01% | -22.2% |
Q3 2021 | $56,785,000 | -26.9% | 2,222,478 | +0.1% | 0.02% | -25.0% |
Q2 2021 | $77,640,000 | +33.3% | 2,220,167 | +26.9% | 0.02% | +26.3% |
Q1 2021 | $58,263,000 | -3.6% | 1,749,123 | -24.9% | 0.02% | -9.5% |
Q4 2020 | $60,453,000 | +3238.1% | 2,330,500 | +1169.7% | 0.02% | +2000.0% |
Q3 2020 | $1,811,000 | -51.0% | 183,547 | -82.9% | 0.00% | -50.0% |
Q2 2020 | $3,698,000 | +173.3% | 1,072,078 | +142.4% | 0.00% | +100.0% |
Q1 2020 | $1,353,000 | -74.2% | 442,209 | -56.6% | 0.00% | -50.0% |
Q4 2019 | $5,240,000 | +176.2% | 1,019,604 | +177.3% | 0.00% | +100.0% |
Q3 2019 | $1,897,000 | +2.3% | 367,693 | +20.0% | 0.00% | 0.0% |
Q2 2019 | $1,854,000 | -11.5% | 306,456 | +5.8% | 0.00% | 0.0% |
Q1 2019 | $2,094,000 | +142.9% | 289,688 | +149.0% | 0.00% | – |
Q4 2018 | $862,000 | +1034.2% | 116,322 | +795.3% | 0.00% | – |
Q3 2018 | $76,000 | +35.7% | 12,992 | -18.8% | 0.00% | – |
Q2 2018 | $56,000 | +69.7% | 15,992 | +0.1% | 0.00% | – |
Q1 2018 | $33,000 | -21.4% | 15,972 | 0.0% | 0.00% | – |
Q4 2017 | $42,000 | -50.0% | 15,972 | 0.0% | 0.00% | – |
Q3 2017 | $84,000 | -94.4% | 15,972 | -96.2% | 0.00% | -100.0% |
Q2 2017 | $1,513,000 | -38.1% | 424,997 | -10.1% | 0.00% | 0.0% |
Q1 2017 | $2,445,000 | +36.4% | 472,935 | +0.2% | 0.00% | 0.0% |
Q4 2016 | $1,793,000 | +2536.8% | 472,005 | +3299.6% | 0.00% | – |
Q3 2014 | $68,000 | -25.3% | 13,884 | -5.7% | 0.00% | – |
Q2 2014 | $91,000 | -26.0% | 14,726 | -36.1% | 0.00% | – |
Q1 2014 | $123,000 | -32.4% | 23,051 | -33.7% | 0.00% | – |
Q4 2013 | $182,000 | +35.8% | 34,753 | +42.6% | 0.00% | – |
Q3 2013 | $134,000 | +119.7% | 24,374 | +0.8% | 0.00% | – |
Q2 2013 | $61,000 | – | 24,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |